Singapore, Oct. 8 -- Germany-based Rentschler Biopharma SE, a leading global contractdevelopment and manufacturing organization (CDMO) for biopharmaceuticals, is highlighting its flexible and optimised solutions for the development and manufacture of a wide range of biologics for clients in Japan and South Korea.

As part of its ongoing commitment and strategic focus on further expanding its services in the region, Rentschler Biopharma will attend BioProcessInternational Asia in Kyoto. The company will also engagewith long-standing and prospective partners to explore joint opportunities and understand evolving needs.

With their well-established and growing biopharma industries, Japan and South Korea are key markets for biopharmaceutical ...